|
HS Code |
465028 |
| Productname | 3-Amino-4-Methylphenylboronic Acid Hydrochloride |
| Casnumber | 877399-42-3 |
| Molecularformula | C7H11BClNO2 |
| Molecularweight | 187.44 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Solubility | Soluble in water and DMSO |
| Storagetemperature | 2-8°C (refrigerated) |
| Synonyms | 3-Amino-4-methylbenzeneboronic acid hydrochloride |
| Smiles | B(C1=CC(=C(C=C1)N)C)(O)O.Cl |
| Inchikey | BJPICUKMXSBSDU-UHFFFAOYSA-N |
As an accredited 3-Amino-4-Methylphenylboronic Acid Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic bottle containing 10 grams, labeled with chemical name “3-Amino-4-Methylphenylboronic Acid Hydrochloride”, CAS number, and safety warnings. |
| Shipping | 3-Amino-4-Methylphenylboronic Acid Hydrochloride is shipped in tightly sealed containers to prevent moisture absorption and contamination. The package is clearly labeled and cushioned against shock. The chemical is typically transported under ambient conditions, unless otherwise specified, and must comply with all relevant safety and regulatory requirements during shipping. |
| Storage | 3-Amino-4-Methylphenylboronic Acid Hydrochloride should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, well-ventilated area, ideally at 2–8°C (refrigerated). Avoid contact with incompatible materials such as strong oxidizers. Handle under inert atmosphere if necessary, and ensure containers are clearly labeled. Store away from food and drink. |
Applications of 3-Amino-4-Methylphenylboronic Acid Hydrochloride in Industrial ManufacturingAs a direct manufacturer of 3-Amino-4-Methylphenylboronic Acid Hydrochloride, we supply this material for highly specialized applications in the pharmaceutical, agrochemical, and advanced material sectors. Below, we detail differentiated industrial applications, outlining compliance benchmarks, processing integration, formulation quantities, and downstream finished goods for each segment. 1. Active Pharmaceutical Ingredient Intermediate for Oncology TherapeuticsThis raw material serves as a critical boronic acid coupling partner during the synthesis of targeted kinase inhibitors and other antineoplastic drug candidates. The boronic acid moiety enables Suzuki-Miyaura cross-coupling to construct aryl-substituted scaffolds, with stringent batch-to-batch quality assurance demanded by API producers. Usage parameters derive from process development for each specific molecule, and integration points depend on therapeutic class being manufactured. Finished oncology APIs are destined for cytostatic agents supplied under global regulatory protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Advanced Organic Electronic Material PrecursorThis compound acts as an essential functional monomer or cross-coupling building block in the creation of organic semiconductors for thin-film transistor (TFT) and organic light-emitting diode (OLED) applications. The amino and methyl groups enhance tunability of electronic properties, and strict control of impurity profiles is required due to device performance sensitivity. End products include patterned organic layers for display and sensor electronics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Active Compound Building BlockManufacturers of proprietary crop protection agents employ this boronic acid to introduce functionalized aromatic units via Suzuki-coupling, supporting the development of novel pesticide and herbicide molecules with targeted bioactivity. Precision in raw material quality ensures plantrace specification compliance and minimizes residual boron content in finished goods, with various agroactive formulations produced for global agricultural supply chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic Reagent Intermediate for Analytical AssaysDiagnostic reagent producers apply this compound in the synthesis of boronate-labeled molecular probes and enzyme substrates for in vitro diagnostic (IVD) assays. Its reactivity supports selective functionalization of phenyl moieties to enable the detection of saccharides, catechols, or enzyme activity, with stringent trace impurity controls needed for reproducibility in analytical environments. Formulation levels and process conditions depend on probe specificity and required fluorescence or colorimetric properties in the final IVD kits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Amino-4-Methylphenylboronic Acid Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Standing at the intersection of synthetic utility and reliability, 3-Amino-4-Methylphenylboronic Acid Hydrochloride has grown essential in the research and development sector. From a chemical manufacturer’s perspective, it feels important to share what distinguishes this compound, not just in the context of catalog entries, but informed by what we’ve learned through years of refining our own synthetic process.
We manufacture this molecule with the chemical model name: 3-amino-4-methylphenylboronic acid hydrochloride. The importance of tight process control becomes clear early on, especially for a compound with both amine and boronic acid functionalities. The manufacturing route frequently involves a carefully orchestrated sequence, introducing each functional group with an eye toward reactivity and purity, all under closely regulated conditions. By using hydrochloride as a stabilizing salt, we manage to deliver the compound in a form less prone to hydrolysis compared to its free base, which is valued highly during shipping and storage.
What arrives at our clients’ labs is a white to off-white crystalline solid. Its solubility in polar solvents, paired with the salt form, makes it easier for researchers to weigh, dissolve, and use in solution-phase chemistry. We routinely supply this material in technical, research, and high-purity grades, ranging from the multi-kilogram scale down to the sub-gram requests typical of early-stage medicinal chemistry. Specification sheets accompany each batch, but the process of quality assurance starts long before packaging—consistent melting point, NMR, HPLC, and water content analysis set the standard.
Forming the hydrochloride salt doesn’t just protect the compound; it simplifies downstream handling. Amine-bearing boronic acids often absorb water or break down in their free forms, especially when exposed to air or variable temperatures—a problem we’ve confronted more than once in our own storage rooms before switching completely to the hydrochloride variant. Moisture uptake not only reduces shelf life, it can introduce unwanted side reactions, particularly in Suzuki-Miyaura and other cross-coupling reactions. Researchers benefit from reproducible behavior when the compound arrives dry, stable, and ready for use, directly traceable to salt formation choices made at the manufacturing level.
Our clients drive us to pay close attention to catalytic cross-coupling application. The amine at the 3-position and the methyl at the 4-position create a unique electronic environment. This directly impacts reactivity, sometimes enhancing yield when forging new C–C or C–N bonds on an aromatic system. Compared to structurally similar compounds, this one finds frequent use in constructing pharmaceutical intermediates, agrochemicals, OLED materials, and advanced polymers.
Chemical stability and purity have dramatic effects on yields and reproducibility in cross-coupling technology. A contamination as slight as one percent can render products unfit for regulatory submission. Those of us responsible for producing these batches carry that weight with every lot—we track each synthesis step, monitor for trace metal content, and run analytics before and after packaging. This approach comes directly from experience, not just regulatory pressure: a batch that shipped years ago, which failed to meet a customer’s expectations in a pilot study, pushed us to refine controls at every process stage.
As a manufacturer, we don’t make decisions on new products in a vacuum. We receive requests for a wide range of substituted phenylboronic acids. The difference between 3-Amino-4-Methylphenylboronic Acid Hydrochloride and its close relatives extends beyond the molecular structure you might see in a diagram.
Take 4-Methylphenylboronic Acid, for example. Without that 3-amino group, its applications narrow, and it responds differently in ligand-coupled reactions, often requiring more forcing conditions. In contrast, 3-Aminophenylboronic Acid Hydrochloride brings the amino group directly adjacent to the boronic acid, changing the way it interacts with catalysts and electrophiles. The 3-amino-4-methyl substitution delivers a blend of steric hindrance and electron-donating effects, opening the door to distinct product profiles. Medicinal chemists return to this compound for a reason—it gives them flexibility in SAR studies, especially where aromatic substitution patterns make the difference between activity and inactivity.
Alternative amine-boronic building blocks may offer some of the same functionality, but subtle changes affect melting point, solubility, and ease of reaction setup. Our own optimization studies show clear performance differences—not always in theory, but in actual pilot-scale reaction outcomes. In conversations with researchers, the feedback is consistent: consistent behavior saves time in screening and scale-ups, and that comes back to batch quality and well-chosen salt forms.
Producing this compound is as much about reliability as it is about chemistry. Seasoned lab technicians can sense issues early—from shifts in reaction color to small deviations in crystallization. Atmospheric controls and filtration steps make up a large part of the hands-on work on the plant floor. Over time, small improvements add up: swapping old dryers for vacuum ovens, recalibrating temperature probes, improving raw material checks. Each step reduces out-of-specification outcomes, cuts waste, and raises the likelihood that the customer receives material that performs identically, batch after batch.
Scale-up does not always go as planned. While smaller runs provide flexibility, the challenge ramps up when demand calls for tens of kilograms. We’ve had pumps fail mid-run and filtration bottlenecks eat up days of work. Addressing these involves preventative maintenance, repeat training sessions, and direct communication between synthetic chemists and quality control analysts. In one instance, a single impurity—barely above detection limits—prompted an overhaul of our isolation procedure, including a switch to new solvents and tweaking the hydrochloride precipitation parameters. The result? Overall purity rose, and customer complaints dropped to zero that quarter.
As regulators raise the bar, we remain focused on compliance, record-keeping, and worker safety. Hazard assessments and personal protective equipment are integrated into our workflow for every batch. Providing accurate documentation to support our product includes not only COAs, but also detailed traceability logs back to original raw materials. Our safety culture stems from real-world events: a single uncontrolled exothermic event in a paired amination run led to a complete review of our risk protocols, extending from fume hood selection to real-time temperature monitoring.
Material handling is unique for compounds like this—powders with micron-scale particle sizes present inhalation hazards and make precise weighing difficult. Improved ventilation systems and antistatic procedures, along with routine training, help mitigate these issues. Each of these features comes less from textbook recommendations than from incidents and improvements experienced firsthand.
We routinely field technical service questions about best practices for storing and using 3-Amino-4-Methylphenylboronic Acid Hydrochloride. Moisture control, solvent choices, and scale-up tricks are not just academic—they flow from our production facilities to yours. Many customers have asked about reliability under high-throughput screening environments; our packaging methods adapt to these requirements, using foil-sealed containers and single-use aliquots upon request.
Some users encounter crystallization or solubility challenges during downstream steps; sharing our own knowledge of compatible solvents and temperature-sensitive stages often helps unlock higher yields. Not every solution comes from our side—a number of improved reaction results came from collaborative pilot studies, with suggestions that prompted us to tweak our synthesis parameters and even reevaluate recommended storage temperatures for lengthy supply chain timelines.
Handling boron compounds brings both opportunities and responsibilities. Our waste streams receive thorough review, and process improvements seek to minimize boron-containing byproducts reaching wastewater. Recovered solvents are purified for reuse after each run, a decision shaped both by rising disposal costs and environmental stewardship. We pursue continuous optimization to lower the use of chlorinated solvents, and our batch documentation system tracks resource and energy consumption on a per-lot basis.
Industry demand for green chemistry solutions remains strong. We’ve participated in pilot projects aimed at catalytic system development that reduces precious metal use and minimizes toxic waste. Many partners expect us to support not just current supply, but also to invest in process changes that will benefit the industry in years to come. By collecting lifecycle data with every lot, we can pinpoint gains—like the transition to more energy-efficient reactors that cut our annual CO2 footprint—and share them transparently with our clients.
Improvements in chemical production don’t arrive overnight. Years of iterative tweaking, setback, and learning from client experience shape the product as much as any raw material. We developed our initial synthetic pathway for 3-Amino-4-Methylphenylboronic Acid Hydrochloride with materials on hand, adapting each stage as feedback arrived from medicinal chemistry and process development teams. Process waste management, reaction reproducibility, and time-to-delivery all improved with investments in both equipment and team training.
In one notable development, we substituted a more selective amination reagent that reduced byproduct formation, halving post-reaction purification time. Our willingness to modify the workflow came after direct input from a long-term partner facing synthetic bottlenecks. Beyond the chemistry itself, digitization of process monitoring—continuous batch tracking and instrument integration—has helped spot quality issues ahead of time. By sharing performance data across teams, we’ve shortened problem-solving timelines and improved new product launch rates.
Research managers and sourcing professionals often face difficult trade-offs between cost, lead time, and product purity. Not every manufacturing setup can deliver all three at once. Our goal—as a manufacturer—is to cut down surprises, making every kilogram as close to the last as possible. Standardizing raw material sources, synchronizing logistics schedules, and holding buffer stock all support continuity. When demand suddenly jumps, our past process documentation lets us ramp output with minimal risk of cross-contamination or specification drift.
We know that many finished products lose value with a single impurity spike. For this, traceability is more than a buzzword. Whenever a process batch turns up outside spec, every stage—from the initial boronic acid preparation to the hydrochloride salt precipitation—gets reanalyzed. Rejections hurt our reputation and cost time, so we’ve invested early in batch analytics, frequent calibrations, and stricter cleanroom procedures.
Market trends never stop moving. Faster drug discovery timelines, rising regulation, and a sharper focus on sustainability keep driving us to do better. Every feedback loop, from site audits to published research, feeds into our next round of process improvements. Looking at where we started and where we are now, shifts in process chemistry, purification technology, and customer communication have all shaped our approach to this compound.
We recognize the ongoing pressure to supply advanced intermediates that save time and costs for downstream partners. As new synthetic methodologies appear in the literature, and as feedback on 3-Amino-4-Methylphenylboronic Acid Hydrochloride accumulates, subsequent product generations can only improve. We take pride not just in making a product that meets technical specifications, but in building relationships with the scientists who push the envelope in their own research. Real progress in chemical manufacturing always has a human face: a process chemist pivoting when a run goes awry, a customer service technician troubleshooting odd shipment events, and a safety officer suggesting layout changes for a safer working environment.
3-Amino-4-Methylphenylboronic Acid Hydrochloride offers more than a molecular tool for laboratory synthesis. Behind every container stands a team of chemists and technicians, drawing on experience, learning from challenges, and committed to consistent quality. The path from raw materials to final product is shaped by the requirements of demanding research, but also by countless feedback cycles with end-users in mind.
Those who depend on this compound know its value goes beyond catalog numbers or regulatory filings. Each new application, every successful synthesis, and each process improvement adds to its reputation as a cornerstone reagent. Reflecting on years of production effort, open communication with partners, and the incremental gains earned through teamwork, it’s clear that quality starts at the source—and, for us, that source is hard work, vigilance, and a constant drive for better results in the real world of chemical manufacturing.